Record Demand for Bio€quity Europe 2024!

Bio€quity Europe 2024 has reached capacity and is sold out. Please click here to join the Wait List.

Please note you may still join Bio€quity Europe 2024 by purchasing a digital pass, which includes two days of virtual partnering.

Those on the Wait List who have registered for a Digital Pass will receive priority review.

Already registered? Log in and begin scheduling your C-level partnering meetings.

Bio€quity Europe 2024 BrochureDownload the latest event brochure to stay informed and up to date

Interested in becoming a Presenting Company for the next Bio€quity Europe in San Sebastián?2024 Presenting Company Class on-stage spots are sold out. Pre-recorded digital presentations remain available and will be waitlisted and prioritized for any in-person slots that open up. All digital presentations include two in-person tickets.

Bio€quity Europe 2024

For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner, and debate critical issues facing the biotech industry.

Join BioCentury, EBD Group, and Regional Host Committee Chair Ysios Capital, May 12-14, 2024, in one of the culinary capitals of the world. Don’t wait to book your ticket to San Sebastian. Last year, Bio€quity sold out.

Rising Above the Noise

This year we will gather in San Sebastián, Spain, Basque Country, to discuss how biotechs can rise above the noise to attract the right investors, partners, and talent.

  • Debate how to stand out from the crowd and reach the discussion stage with investors and pharma.
  • Meet VCs, CEOs, and BD&L leaders in an intimate setting designed for networking and discussion.
  • Discover 100+ emerging biotechs selected for the Presenting Company Track.
  • Dive into European biotech trends with an exclusive conference report from Insights Partner McKinsey & Company.
  • Schedule one-to-one meetings; check out the Poster Session; take your conversation outside, onto the beach.

BioCentury-BayHelix East-West Summit Podcast: Preview

Listen to "BioCentury This Week" for a preview of Bio€quity Europe 2024.

Bio€quity Europe 2024 Preview


Roel Bulthuis
Managing Partner
Syncona Investment Management Ltd.
Erica Whittaker, Ph.D.
VP & Head Corporate Venture Fund
UCB Ventures
Kate Bingham
Managing Partner
SV Health Investors
Naveed Siddiqi
Senior Partner
Novo Holdings
Alexandra Zemp, Ph.D.
McKinsey & Company
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
View More Facultyright-arrow


Sponsorship opportunities available for Bio€quity Europe 2024Speak with a BioCentury representative today

Presenting Companies



“Bio€quity brings together top stakeholders in the life sciences European VC space. The event stands out by delivering quality thought leadership. For the biotech VC community, this is Europe’s flagship event.” 

Nanna Lüneborg, Ph.D.
General Partner

“Bio€quity Europe is a 'must go' for both VCs and CEOs of life science companies in Europe ... it is THE event where you can feel the pulse of the industry ...”

Antoine Papiernik
Chairman & Managing Partner
Sofinnova Partners

"Bio€quity is the leading event for the biotech industry in Europe. A masterfully organized event, it brings all actors together and creates an atmosphere and platform for true networking and business development. Complement that with a rich insights agenda that materially contributes to the discussion in the industry and the region, and you have an unmissable event." 

Jorge Santos da Silva, Ph.D.
MoonLake Immunotherapeutics AG

"Bio€quity Europe is a great meeting for strategic discussions about access to capital and talent. It’s also a key networking event for investors and biopharma executives in Europe."​

Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics